• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Rep . Combining antigenic data from public sources gives an early indication of the immune escape of emerging virus variants

tetano

Editor, Senior Moderator
Sci Rep


. 2025 Oct 24;15(1):37193.
doi: 10.1038/s41598-025-19578-3. Combining antigenic data from public sources gives an early indication of the immune escape of emerging virus variants

Antonia Netzl[SUP] 1 [/SUP], Sina Türeli[SUP] 1 [/SUP], Eric B LeGresley[SUP] 1 [/SUP], Barbara Mühlemann[SUP] 2 3 [/SUP], Samuel H Wilks[SUP] 1 [/SUP], Derek J Smith[SUP] 4 [/SUP]



Affiliations
Abstract

The rapid spread of the Omicron BA.1 (B.1.1.529.1) SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) variant in 2021 resulted in international efforts to quickly assess its escape from immunity generated by vaccines and previous infections. Numerous laboratories published BA.1 neutralization data as preprints and reports. We collated this data in real time and regularly presented updates of the aggregated results in US, European and WHO research and advisory settings. Here, we retrospectively analyzed the accuracy of these aggregations from 85 different sources published during a time period from 2021/12/08 up to 2022/08/14. We found that the mean titer fold change from wild type-like variants to BA.1, a standard measure of a variant's immune escape, remained stable after the first 15 days of data reporting in people who were twice vaccinated, and incoming data increased the confidence in this quantity. Further, it is possible to build reliable, stable antigenic maps from this collated data already after one month of incoming data. We here demonstrate that combining early reports from variable, independent sources can rapidly indicate a new virus variant's immune escape and can therefore be of immense benefit for public health.

Keywords: Antigenic cartography; BA.1; Immune escape; Public data; Public health; SARS-CoV-2.

 
Back
Top Bottom